Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.
Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.
Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.
Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.
The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.
bit.bio Chief Operating Officer Kathryn Corzo featured in Endpoints News.
This feature covers the latest fundraise and appointments to the board.
bit.bio adds $100M+ to its coffers and some impressive names to its board of directors.
The book celebrates leadership and innovation and covers bit.bio's ambition to engineer the future of medicine.
Short film showcases innovative cell reprogramming technology at event.
Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.
This piece covers what's different about our cell coding approach.